Litviakov, N. V., & Kzhyshkowska, J. (2018). Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy. Cancer chemotherapy and pharmacology, 82(1), . https://doi.org/10.1007/s00280-018-3594-8
Chicago-Zitierstil (17. Ausg.)Litviakov, Nikolai V., und Julia Kzhyshkowska. "Expression of M2 Macrophage Markers YKL-39 and CCL18 in Breast Cancer Is Associated with the Effect of Neoadjuvant Chemotherapy." Cancer Chemotherapy and Pharmacology 82, no. 1 (2018). https://doi.org/10.1007/s00280-018-3594-8.
MLA-Zitierstil (9. Ausg.)Litviakov, Nikolai V., und Julia Kzhyshkowska. "Expression of M2 Macrophage Markers YKL-39 and CCL18 in Breast Cancer Is Associated with the Effect of Neoadjuvant Chemotherapy." Cancer Chemotherapy and Pharmacology, vol. 82, no. 1, 2018, https://doi.org/10.1007/s00280-018-3594-8.